FIELD: medicine.
SUBSTANCE: invention refers to medicine and concerns methods of treating diseases with using VEGF antagonists. Substance of the invention involves application of a VEGF antagonist containing VEGFR1R2-FcΔ C1 (a) SEQ ID NO:4 in preparing a drug for hypertension reduction, in treating the diseases associated with administering the VEGF antagonist where the treatment is conducted by subcutaneous introduction.
EFFECT: advantage of the invention consists in reducing side effects associated with treating the diseases by administering the VEGF antagonist.
8 cl, 3 ex, 1 tbl
Authors
Dates
2011-03-27—Published
2006-08-11—Filed